Patient Diversity: Strategies and Organizational Approaches

Report Overview

Appropriate demographic representation in clinical trials can help ensure that a therapy’s effects, including safety and efficacy outcomes, are understood across various patient characteristics such as race/ethnicity, gender, age, health status, socioeconomic status, and geographic location. Individuals from minority populations have historically been underrepresented in clinical research, often bear a disproportionate disease burden, and many are underserved by the healthcare industry. Increasing the diversity of clinical trial participants has become a goal for many organizations in the biopharmaceutical space; however, improving patient diversity is easier said than done.

The primary intent of this research is to provide perspective on how sponsors and CROs are approaching the topic of patient diversity in clinical trials. ISR surveyed 100 individuals from sponsor organizations and CROs who are involved with developing plans and tactics to improve patient diversity to understand organizational approaches and best practices. ISR also conducted in-depth interviews with 10 of these respondents to gather more detailed insights.

With this report, we invite readers to understand how sponsors and CROs are working to increase patient diversity in clinical trials, strategies that have been the most successful, and challenges they are working to overcome.
 

What you will learn:

Strategies and Challenges:

• Assess strategies respondents are using to improve patient diversity and their takes on which have been the most successful to consider which practices might be impactful for your company’s trials
• Read examples of how different types of technology and vendors are being used to improve patient diversity
• Gain an understanding of the challenges others encounter when working to improve diversity

Organizational Approaches:

• Gather information on organizational approaches to improving patient diversity, including the use of dedicated staff, dedicated budgets, and reporting structures
• Understand the level of importance placed on patient diversity and which demographic characteristics organizations are focusing on
• Learn how organizations track progress toward diversity goals and what happens if goals are not met
• Compare your company’s approach to patient diversity to that of other organizations

Major Topics:

• Importance of Improving Patient Diversity in Clinical Trials
• Organizational Approaches to Improving Patient Diversity in Clinical Trials
• Strategies to Improve Patient Diversity in Clinical Trials
• Challenges to Improving Patient Diversity in Clinical Trials